Moreover, our GEO study found that the group with superficial transitional cell carcinoma with surrounding carcinoma in situ lesions, or the invasive carcinoma group had higher expression of ADAM9, further supporting the cell migration promoting the function of ADAM9. This evidence concerns the gene ADAM9 and in situ carcinoma.